Skip Navigation
Return to All Schools

Leadership and Innovation Endowed Chair

School of Nursing
Public Health

Established in 2021 by an anonymous donor

The chair was funded to support the School of Nursing’s Diversity Signature Initiative to recognize exemplary nurse scholars from racial, ethnic and gender minority groups, bolster a diverse workforce, and improve health outcomes among underrepresented communities and populations.

Held by Jason Farley

JASON FARLEY, Ph.D., MPH, ANP-BC, FAAN, AACRN, is a world-renowned nurse scientist and the inaugural Leadership and Innovation Endowed Chair at the Johns Hopkins University School of Nursing. He directs the Center for Infectious Disease and Nursing Innovation. As an Infectious Disease Nurse Epidemiologist and a Nurse Practitioner in the Division of Infectious Diseases at The Johns Hopkins School of Medicine, his clinical practice in the John Bartlett Specialty Practice spans HIV prevention, treatment and associated co-infections.

Dr. Farley’s research seeks to optimize a patient’s diagnostic experience, linkage to care, and their retention in care for a variety of infectious diseases. He designs multi-component interventions to build an equitable care experience tailored to the patient’s individual needs.  Dr. Farley leads a cluster randomized trial [R01AI104488] designed to tailor nurse case management for persons with drug-resistant Tuberculosis and HIV co-infection in South Africa and a co-investigator on an adaptive, SMART trial [R01 NR016650], which involves an adaptive randomized evaluation of nurse-led HIV treatment and retention interventions for female sex workers living with HIV, also in South Africa.  He and his team recently received a Discovery Award from Johns Hopkins University to conduct a randomized controlled trial to improve treatment adherence and retention in care for patients with TB and HIV co-infection using a combined community health worker armed with digital adherence technology to escalate adherence support in real-time.  In an ongoing interventional cohort in Baltimore City, his community health worker model offers an ‘unapologetically enabling’ approach to achieve equitable access, retention and engagement for patients struggling with viral suppression. His team is responding directly to the COVID-19 pandemic and recently receiving a NIH Center for AIDS Research supplement to conduct a comparative effectiveness trial of COVID-19 testing modalities.

Dr. Farley earned his Ph.D. and his MSN at the Johns Hopkins School of Nursing, his MPH at the University of Alabama Birmingham (UAB), and his BSN at the University of Alabama (UA).